Terms: = Skin cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
55 results:
1. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Mitra A; Thompson B; Strange A; Amato CM; Vassallo M; Dolgalev I; Hester-McCullough J; Muramatsu T; Kimono D; Puranik AS; Weber JS; Woods D
Clin Cancer Res; 2023 Oct; 29(20):4242-4255. PubMed ID: 37505479
[TBL] [Abstract] [Full Text] [Related]
4. Adverse health outcomes among rural prostate cancer survivors: A population-based study.
Huang D; Chang CE; Newman M; Deshmukh V; Snyder J; Date A; Galvao C; Lloyd S; Henry NL; O'Neil B; Hashibe M
Cancer Epidemiol; 2023 Oct; 86():102430. PubMed ID: 37473579
[TBL] [Abstract] [Full Text] [Related]
5. IL-7R licenses a population of epigenetically poised memory CD8
Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
[TBL] [Abstract] [Full Text] [Related]
6. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
Congur I; Koni E; Onat OE; Tokcaer Keskin Z
PeerJ; 2023; 11():e15250. PubMed ID: 37096065
[TBL] [Abstract] [Full Text] [Related]
7. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.
Qu R; Kluger Y; Yang J; Zhao J; Hafler DA; Krause DS; Bersenev A; Bosenberg M; Hurwitz M; Lucca L; Kluger HM
Mol Cancer; 2022 Dec; 21(1):219. PubMed ID: 36514045
[TBL] [Abstract] [Full Text] [Related]
8. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
[TBL] [Abstract] [Full Text] [Related]
9. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution.
Li X; Zhao S; Bian X; Zhang L; Lu L; Pei S; Dong L; Shi W; Huang L; Zhang X; Chen M; Chen X; Yin M
Theranostics; 2022; 12(17):7532-7549. PubMed ID: 36438481
[No Abstract] [Full Text] [Related]
10. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
[TBL] [Abstract] [Full Text] [Related]
11. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-7 regulates cd127 expression and promotes CD8
He H; Qiao B; Guo S; Cui H; Zhang Z; Qin J
BMC Immunol; 2022 Jul; 23(1):35. PubMed ID: 35850640
[TBL] [Abstract] [Full Text] [Related]
13. Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics.
Li G; Zhang J; Liu Y; Cheng X; Sun K; Hong W; Sha K
Comput Intell Neurosci; 2022; 2022():4493347. PubMed ID: 35300397
[TBL] [Abstract] [Full Text] [Related]
14. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
[TBL] [Abstract] [Full Text] [Related]
15. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract] [Full Text] [Related]
16. Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma.
He H; Qiao B; Guo S; Cui H; Li N; Liu H; Qin J; He J; Yang X; Xue W; Wang Y
Melanoma Res; 2021 Aug; 31(4):328-337. PubMed ID: 34054059
[TBL] [Abstract] [Full Text] [Related]
17. Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors.
Grigoriou M; Banos A; Hatzioannou A; Kloetgen A; Kouzis P; Aggouraki D; Zakopoulou R; Bamias G; Kassi E; Mavroudis D; Bamias A; Boumpas DT; Tsirigos A; Gogas H; Alissafi T; Verginis P
Cancer Immunol Res; 2021 Jul; 9(7):726-734. PubMed ID: 33820810
[TBL] [Abstract] [Full Text] [Related]
18. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
Novik AV; Protsenko SA; Baldueva IA; Berstein LM; Anisimov VN; Zhuk IN; Semenova AI; Latipova DK; Tkachenko EV; Semiglazova TY
Oncologist; 2021 May; 26(5):364-e734. PubMed ID: 33749049
[TBL] [Abstract] [Full Text] [Related]
19. Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes.
Woods DM; Laino AS; Winters A; Alexandre J; Freeman D; Rao V; Adavani SS; Weber JS; Chattopadhyay PK
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369447
[TBL] [Abstract] [Full Text] [Related]
20. Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children.
Whangbo JS; Kim HT; Mirkovic N; Leonard L; Poryanda S; Silverstein S; Kim S; Reynolds CG; Rai SC; Verrill K; Lee MA; Margossian S; Duncan C; Lehmann L; Huang J; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Blazar BR; Antin JH; Soiffer RJ; Ritz J; Koreth J
Blood Adv; 2019 Sep; 3(17):2550-2561. PubMed ID: 31471324
[TBL] [Abstract] [Full Text] [Related]
[Next]
